Ketamine Therapy in Patients of Alcohol Use Disorder: A Prospective Pilot Study to Evaluate Abstinence Rate with This Add-on Treatment Modality

被引:0
|
作者
Marvania, Nidhi Purushottum [1 ]
Rayan, Anto Leroy [1 ]
Merchant, Dhruti Vijaykumar [1 ]
Shah, Drashti Paragkumar [1 ]
Mehta, Prakash Ishwarlal [1 ]
Modh, Fenil Dineshkumar [1 ]
机构
[1] GMERS Med Coll & Hosp, Dept Psychiat, Ahmadabad, Gujarat, India
关键词
Abstinence and craving; alcohol use disorder; ketamine therapy; paired t-test; EFFICACY;
D O I
10.4103/aip.aip_110_24
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Alcohol use disorders (AUDs) are emerging as a substance use disorder having various psychological and physical ill effects leading to hampering of individual's productivity and functioning. Aims: The aim of this study was to evaluate the efficacy of ketamine in enhancing confidence levels to abstain from alcohol. Methods: Eighteen patients were administered ketamine intravenously after detoxification; a total of three doses, with a 3-day gap between each. The Alcohol Abstinence Self-Efficacy Scale was used to measure their confidence in abstaining from alcohol. Results: The study revealed a significant increase in mean confidence scores after three ketamine sessions, with a final assessment showing a 51.98% increase in confidence from baseline. Conclusions: The study found that ketamine therapy significantly increased confidence levels in individuals with AUD to abstain from alcohol, with P = 0.05 threshold. However, the impact may wane over time, suggesting the need for additional support or maintenance treatments.
引用
收藏
页码:324 / 327
页数:4
相关论文
共 50 条
  • [31] BDNF CpG methylation and serum levels covary during alcohol withdrawal in patients with alcohol use disorder: A pilot study
    Lacroix, Aurelie
    Ramoz, Nicolas
    Girard, Murielle
    Plansont, Brigitte
    Poupon, Daphnee
    Gorwood, Philip
    Nubukpo, Philippe
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2023, 24 (09) : 854 - 859
  • [32] A Comparison of the Antihypertensive and Anti-Inflammatory Effects of Aliskiren and Ramipril Add-On Therapy in Peritoneal Dialysis Patients - A Pilot Open Label Study
    Makowka, Agnieszka
    Olejniczak-Fortak, Magdalena
    Nowicki, Michal
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01) : 18 - 25
  • [33] Blended Treatment for Alcohol Use Disorder (Blend-A): Explorative Mixed Methods Pilot and Feasibility Study
    Tarp, Kristine
    Rasmussen, Johan
    Mejldal, Anna
    Folker, Marie Paldam
    Nielsen, Anette Sogaard
    JMIR FORMATIVE RESEARCH, 2022, 6 (04)
  • [34] Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy
    Gross, Manfred
    Neuschwander, Dennis
    Steffens, Lisa
    Thomsen, Joern
    Roeschmann-Doose, Kristina
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [35] Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study
    Maschio, Marta
    Dinapoli, Loredana
    Sperati, Francesca
    Pace, Andrea
    Fabi, Alessandra
    Vidiri, Antonello
    Pompili, Alfredo
    Carapella, Carmine Maria
    EPILEPTIC DISORDERS, 2012, 14 (04) : 388 - 397
  • [36] Joint versus separate inpatient rehabilitation treatment for patients with alcohol use disorder or drug use disorder: an observational study
    Bender, Stefan
    Specka, Michael
    Buchholz, Angela
    Hoelscher, Stefan
    Rist, Fred
    Heinz, Thomas W.
    Schifano, Fabrizio
    Scherbaum, Norbert
    SUBSTANCE ABUSE AND REHABILITATION, 2018, 9 : 23 - 29
  • [37] A Pilot Study of Switching Electroconvulsive Therapy for Patients With Treatment Resistant Schizophrenia or Mood Disorder
    Tan, Xiao Wei
    Oon, Li Keat
    Tsang, Yun Ying Tammy
    Ong, Hatta Santoso
    Tor, Phern Chern
    JOURNAL OF ECT, 2021, 37 (03) : 202 - 206
  • [38] Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)
    Abril Jaramillo, Javier
    Estevez Maria, Jose Carlos
    Giron Ubeda, Juan Miguel
    Vega Lopez, Oscar
    Calzado Rivas, Maria Elena
    Perez Diaz, Hernando
    Garcia Martin, Guillermina
    Vila Herrero, Elena
    Chamorro-Munoz, M.
    Vazquez, F.
    De la Fuente, C.
    Redondo, L.
    Pelaez, N.
    Santagueda, Patricia
    Rodriguez Uranga, Juan Jesus
    EPILEPSY & BEHAVIOR, 2020, 102
  • [39] Care outcomes and alcohol-related treatment utilisation profiles of patients with alcohol-use disorder A prospective cohort study using electronic health records
    Rautiainen, Elina
    Ryynanen, Olli-Pekka
    Laatikainen, Tiina
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2018, 35 (05) : 329 - 343
  • [40] Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study
    Althobaiti, Fahad M.
    Alsanosi, Safaa M.
    Falemban, Alaa H.
    Alzahrani, Abdullah R.
    Fataha, Salma A.
    Salih, Sara O.
    Alrumaih, Ali M.
    Alotaibi, Khalid N.
    Althobaiti, Hazim M.
    Al-Ghamdi, Saeed S.
    Ayoub, Nahla
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)